Evidence map›Paper›PMID 32985606›Full record

ArticleScientific reports2020

Annurca apple polyphenol extract promotes mesenchymal-to-epithelial transition and inhibits migration in triple-negative breast cancer cells through ROS/JNK signaling.

Daniela Cristina Vuoso, Stefania D'Angelo, Rosalia Ferraro, Sergio Caserta, Stefano Guido, Marcella Cammarota, Marina Porcelli, Giovanna Cacciapuoti

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Cytoprotective Potential ofInternational journal of molecular sciences · 2025
    Article
  7. Antioxidant Activity ofAntioxidants (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. iMaterials today. Bio · 2024
    Article
  12. International journal of molecular sciences · 2023
    Article
  13. Review
  14. Article
  15. Roles of the cytoskeleton in human diseases.Molecular biology reports · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Effects ofOxidative medicine and cellular longevity · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Daniela Cristina VuosoDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 7, 80138, Naples, Italy.
Stefania D'AngeloDepartment of Motor Sciences and Wellness, "Parthenope" University, Via Medina 40, 80133, Naples, Italy.
Rosalia FerraroDepartment of Chemical, Materials and Industrial Production Engineering (DICMAPI), University of Naples Federico II, P.le Tecchio 80, 80125, Naples, Italy.
Sergio CasertaDepartment of Chemical, Materials and Industrial Production Engineering (DICMAPI), University of Naples Federico II, P.le Tecchio 80, 80125, Naples, Italy.
Stefano GuidoDepartment of Chemical, Materials and Industrial Production Engineering (DICMAPI), University of Naples Federico II, P.le Tecchio 80, 80125, Naples, Italy.
Marcella CammarotaDepartment of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 80138, Naples, Italy.
Marina PorcelliDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 7, 80138, Naples, Italy.
Giovanna CacciapuotiDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio 7, 80138, Naples, Italy. giovanna.cacciapuoti@unicampania.it.
University of Campania "Luigi Vanvitelli" · ITCeinge Biotecnologie Avanzate (Italy) · ITParthenope University of Naples · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant activation of epithelial-to-mesenchymal transition has been shown to correlate with triple-negative breast cancer (TNBC) progression and metastasis. Thus, the induction of the reverse process might offer promising opportunities to restrain TNBC metastatic spreading and related mortality. Recently, the Annurca apple polyphenol extract (APE) has been highlighted as a multi-faceted agent that selectively kills TNBC cells by ROS generation and sustained JNK activation. Here, by qualitatively and quantitatively monitoring the real-time movements of live cells we provided the first evidence that APE inhibited the migration of MDA-MB-231 and MDA-MB-468 TNBC cells and downregulated metalloproteinase-2 and metalloproteinase-9. In MDA-MB-231 cells APE decreased SMAD-2/3 and p-SMAD-2/3 levels, increased E-cadherin/N-cadherin protein ratio, induced the switch from N-cadherin to E-cadherin expression and greatly reduced vimentin levels. Confocal and scanning electron microscopy imaging of APE-treated MDA-MB-231 cells evidenced a significant cytoskeletal vimentin and filamentous actin reorganization and revealed considerable changes in cell morphology highlighting an evident transition from the mesenchymal to epithelial phenotype with decreased migratory features. Notably, all these events were reverted by N-acetyl-L-cysteine and JNK inhibitor SP600125 furnishing evidence that APE exerted its effects through the activation of ROS/JNK signaling. The overall data highlighted APE as a potential preventing agent for TNBC metastasis.

Indexed as

ApoptosisCadherinsCell Line, TumorCell MovementChlorogenic AcidEpithelial-Mesenchymal TransitionFemaleFlavonoidsHumansMAP Kinase Signaling SystemReactive Oxygen SpeciesTanninsTriple Negative Breast NeoplasmsVimentinapple polyphenol extractCadherinsChlorogenic AcidFlavonoidsReactive Oxygen SpeciesTanninsVimentin

Identifiers

PMID32985606
PMCPMC7522716
OpenAlexW3088095368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.